Racial/ethnic minorities underrepresented in Alzheimer’s neuroimaging research
Jul 28, 2023
Sample diversity has improved recently, with proportion of Blacks increasing from 3.39% in 1994-2017 to 8.29% in 2018-2022.
Gantenerumab does not slow clinical decline in early Alzheimer’s disease
Nov 16, 2023
Two trials show a lower amyloid plaque burden with gantenerumab versus placebo at 116 weeks.
Care navigation can supplement dementia care workforce, fill in care gaps: report
By
Kimberly Bonvissuto
Mar 23, 2023
Investing in care navigation — and care navigators — will help individuals living with Alzheimer’s disease and related dementias and their caregivers overcome barriers, according to a new report...
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.
Napping may be a sign of approaching Alzheimer’s
By
John O'Connor
Aug 13, 2019
When residents begin to take more naps, it might not just be that they are tired. New research indicates it might be an early warning sign of advancing Alzheimer’s disease.
Bill Gates sets aside $100 million for Alzheimer’s research
By
John O'Connor
Nov 14, 2017
Billionaire Bill Gates announced he will invest $50 million in the Dementia Discovery Fund. The venture capital fund links targets the disease by coordinating public and private-sector efforts.
Senior living community helps teach future physicians, learn from caregivers
By
Lois A. Bowers
Jul 14, 2016
A Florida assisted living and memory care community is partnering with a local university to help address two issues associated with the United States’ expanding aging population: The lack of geriatricians...
Study: Dementia incidence may be declining
By
Lois A. Bowers
Feb 10, 2016
Despite concern about a potential increase of cases of dementia in an aging population over the next few decades, a new study suggests that the rate of new cases of dementia actually may be decreasing.
Clinton shares Alzheimer’s plans
By
Lois A. Bowers
Dec 22, 2015
Democratic presidential candidate Hillary Clinton unveiled a plan Dec. 22 to invest $2 billion per year to prevent, treat and make possible a cure for Alzheimer’s disease by the year 2025 if she...
Lilly to seek FDA approval for new drug for Alzheimer’s disease
Jun 25, 2021
Donanemab already has received a ‘breakthrough therapy’ designation from the FDA.